Boehringer Ingelheim Korea Wins Medicine-Research Award
This article was originally published in PharmAsia News
Executive SummarySouth Korea's Boehringer Ingelheim Korea, a unit of the Germany-based company, has won the nation's version of the Nobel Prize in medicine. Supporters of the award cited the firm's leadership in helping to promote medical research. The award is known as the Wunsch Award, established in 1990 by Boehringer Ingelheim Korea in conjunction with the Korea Academy of Medical Sciences. (Click here for more
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.